Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

16.2K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.2K
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modification of RECIST 1.1 criteria for assessing response in breast tumours treated with radiation therapy using multiparametric breast MRI: Radiology and oncology perspective.

Breast (Edinburgh, Scotland)·2026
Same author

Radiotherapy Plan Quality Assurance in the ABC-07 Trial of Stereotactic Body Radiotherapy for Locally Advanced Biliary Tract Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Women in radiation oncology: are there barriers to realising our potential, how do these compare to other oncological disciplines, and how might we overcome them?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Testing a 5-fraction Simultaneous Integrated Boost in Radiotherapy for Breast Cancer: The UK FAST-Forward Boost Trial Opens to Recruitment.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

ESMO open·2025

Related Experiment Video

Updated: Oct 1, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

How Low Can You Go? The Radiobiology of Hypofractionation.

D H Brand1, A M Kirby2, J R Yarnold2

  • 1The Institute of Cancer Research, London, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|March 9, 2022
PubMed
Summary

Hypofractionated radiotherapy, using fewer, larger doses, is standard for prostate and breast cancers. This review explores its effects on toxicity and tumor control, considering radiobiology principles for ultrahypofractionated schedules.

Keywords:
Hypofractionationradiobiology

More Related Videos

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

7.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Related Experiment Videos

Last Updated: Oct 1, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments
06:08

Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments

Published on: May 26, 2019

7.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Area of Science:

  • Radiation Oncology
  • Radiobiology
  • Clinical Cancer Research

Background:

  • Hypofractionated radical radiotherapy is a standard treatment for various cancers, including prostate and breast.
  • Research is advancing towards ultrahypofractionated schedules, with some already adopted in clinical practice.
  • Hypofractionation impacts key clinical outcomes: acute and late toxicity, and local tumor control.

Purpose of the Study:

  • To review the effects of hypofractionation on radiotherapy clinical endpoints.
  • To discuss these effects through the lens of the 5 Rs of radiobiology.
  • To consider non-canonical radiobiological effects relevant to ultrahypofractionated radiotherapy.

Main Methods:

  • Literature review focusing on radiobiological principles and clinical outcomes.
  • Analysis of the impact of hypofractionation on acute and late toxicity.
  • Evaluation of effects on local tumor control.

Main Results:

  • Hypofractionation influences acute toxicity, late toxicity, and local control differently.
  • The 5 Rs of radiobiology provide a framework for understanding these effects.
  • Non-canonical radiobiological effects are increasingly relevant for ultrahypofractionation.

Conclusions:

  • Understanding radiobiological principles is crucial for interpreting clinical data on hypofractionated radiotherapy.
  • This review provides insights to aid in the interpretation of ultrahypofractionated treatment data.
  • The principles discussed can guide the application and understanding of advanced radiotherapy schedules.